Patents by Inventor Sebastiano Bianco

Sebastiano Bianco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9132109
    Abstract: A method for treating non-asthmatic bronchitis with a particular lysine acetylsalicylate is described. The lysine acetylsalicylate is delivered by nebulizer, preferably, to treat acute bronchitis, chronic bronchitis, emphysema and chronic obstructive pulmonary disease.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: September 15, 2015
    Assignee: MEDESTEA RESEARCH & PRODUCTION S.P.A.
    Inventors: Jose Sebastian Franzone, Sebastiano Bianco, Giuseppe Zuccari, Claudio Franco Omini
  • Publication number: 20080306033
    Abstract: This invention claims the use of non-steroidal anti-inflammatory drugs, and in particular lysine acetylsalicylate, delivered by nebuliser, to treat non-asthmatic bronchitis, namely acute bronchitis, chronic bronchitis, emphysema and chronic obstructive pulmonary disease.
    Type: Application
    Filed: March 10, 2006
    Publication date: December 11, 2008
    Applicant: MEDESTA RESEARCH & PRODUCTION S.P.A.
    Inventors: Jose Sebastian Franzone, Sebastiano Bianco, Giuseppe Zuccari, Claudio Franco Omini
  • Patent number: 6051566
    Abstract: Non-steroidal anti-inflammatory drugs proved to be effective drugs for combating and preventing asthma if administered by inhalation. Useful are for instance acetylsalicylic acid, and indomethacin, and ketoprofen, and tenoxicam. Suitable pharmaceutical compositions for inhalation are aerosols with a particle size of from 0.5 .mu.m to 7 .mu.m which enter the compartments of the lungs. Aqueous or aqueous-organic solutions or suspensions can be nebulized in combination with propelling agents, or mixtures of powders with microfine drugs can be administered using inhalers. These pharmaceutical compositions may comprise appropriate additives, in order to improve their relevant pharmaceutical properties.
    Type: Grant
    Filed: March 2, 1998
    Date of Patent: April 18, 2000
    Assignee: B.S.D. Bio Science Development SNC DI Omini C. & Zuccari G.
    Inventor: Sebastiano Bianco
  • Patent number: 5750559
    Abstract: The antireactive-antiasthmatic effect of inhaled loop diuretics is potentiated by the use of a combination of a loop diuretic and a non-steroidal anti-inflammatory drug as an inhalant for combating asthma. The use of a cyclooxygenase inhibitor as the non-steroidal anti-inflammatory drug is preferred, particularly preferred is the use of furosemide as the loop diuretic. Especially advantageous is the use of piretanide as the loop diuretic. Particularly preferred is the use of acetylsalicylic acid as the non-steroidal anti-inflammatory drug.The most remarkable finding of this invention is the excellent and steady protective effect afforded by the combination of the two drugs in the patients with late asthmatic reactions between the seventh and eighth hour, when the effect of treatment with either drug alone appeared to be progressively decreasing.
    Type: Grant
    Filed: August 5, 1994
    Date of Patent: May 12, 1998
    Assignee: Sebastiano Bianco
    Inventor: Sebastiano Bianco
  • Patent number: 5392767
    Abstract: Loop diuretics, particularly their well known representative furosemide, are effective drugs for the treatment of allergen-induced nasal reactions, if a solution of the loop diuretic is nebulized into the nostrils.
    Type: Grant
    Filed: November 7, 1991
    Date of Patent: February 28, 1995
    Assignee: Hoechst Aktiengesellschaft
    Inventor: Sebastiano Bianco
  • Patent number: 5366967
    Abstract: The antireactive-antiasthmatic effect of inhaled loop diuretics is potentiated by the use of a combination of a loop diuretic and a non-steroidal anti-inflammatory drug as an inhalant for combating asthma. The use of a cyclooxygenase inhibitor as the non-steroidal anti-inflammatory drug is preferred, particularly preferred is the use of furosemide as the loop diuretic. Especially advantageous is the use of piretanide as the loop diuretic. Particularly preferred is the use of acetylsalicylic acid as the non-steroidal anti-inflammatory drug.The most remarkable finding of this invention is the excellent and steady protective effect afforded by the combination of the two drugs in the patients with late asthmatic reactions between the seventh and eighth hour, when the effect of treatment with either drug alone appeared to be progressively decreasing.
    Type: Grant
    Filed: May 21, 1993
    Date of Patent: November 22, 1994
    Assignee: Hoechst Aktiengesellschaft
    Inventor: Sebastiano Bianco
  • Patent number: 5258374
    Abstract: Furosemide ##STR1## is used as medicament for the treatment of allergic conjunctivitis; it is dropped into the conjunctival fornix of the eye.
    Type: Grant
    Filed: July 18, 1991
    Date of Patent: November 2, 1993
    Assignee: Hoechst Aktiengesellschaft
    Inventor: Sebastiano Bianco
  • Patent number: 4908382
    Abstract: Inhaled furosemide is an effective agent for preventing asthma attacks.
    Type: Grant
    Filed: February 9, 1989
    Date of Patent: March 13, 1990
    Assignee: Hoechst Aktiengesellschaft
    Inventor: Sebastiano Bianco